🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study is looking at outcomes in people with advanced cancers who have ...
Status
Terminated
Location
Peter MacCallum Cancer Centre
Start Date
2021-09-23
Trial ID
NCT04801966
Ameloblastoma is the most common benign odontogenic tumor, characterized by...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2025-03-01
Trial ID
NCT06819605
Treatments Being Tested
GSK1120212 is a potent and highly selective inhibitor of MEK phosphorylatio...
Status
Completed
Location
GSK Investigational Site
Start Date
2010-08
Trial ID
NCT01231581
Treatments Being Tested
This is a phase 2 study (the second phase in testing a new drug or combinat...
Status
Completed
Location
Juravinski Cancer Center
Start Date
2016-04
Trial ID
NCT02428270
Treatments Being Tested
This clinical trial is to clarify whether treatment with a checkpoint inhib...
Status
Recruiting
Location
Herlev Universityhospital
Start Date
2018-06-06
Trial ID
NCT03563729
This research study is studying a combination of targeted therapies as a po...
Status
Completed
Location
Dana Farber Cancer Institute
Start Date
2018-09-10
Trial ID
NCT03455764
Treatments Being Tested
This is a global, multi-centre, open-label, study of GSK2118436 conducted i...
Status
Terminated
Location
GSK Investigational Site
Start Date
2014-04-08
Trial ID
NCT01978236
Treatments Being Tested
The purpose of this study was to evaluate safety and efficacy of the combin...
Status
Terminated
Location
California Cancer Associates for Research and Excellence
Start Date
2017-02-17
Trial ID
NCT02967692
Treatments Being Tested
This was a Phase II, open-label, non-randomized, multi-center study of oral...
Status
Completed
Location
Novartis Investigative Site
Start Date
2014-03-12
Trial ID
NCT02034110
Treatments Being Tested
A Phase I, single-center, open-label, single-persiod, combined single dose ...
Status
Completed
Location
GSK Investigational Site
Start Date
2011-06-20
Trial ID
NCT01416337
Treatments Being Tested